We specialize in helping companies navigate the critical period between Phase 3 read-out and product launch. For 15 years we’ve partnered with a wide range of pharmaceutical companies, from some of the world’s largest drug firms to start-ups and emerging leaders. Our more than 70 launches include:
- A breakthrough breast cancer drug
- A treatment for a rare disease derived from corn cells
- An opioid pain medication with an innovative abuse deterrent
We even helped launch a drug that keeps dogs calm during thunderstorms.
Our unique approach to launch management streamlines a complicated process. We’re intimately familiar with the industry’s quirks and subtleties, and our guidance is straightforward, practical and effective.